CollPlant Biotechnologies (CLGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.62, -1.49% vs the prior close of $3.68.
- Volume 13.38K shares, 0.0x its 50-day average (light).
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
CLGN dips 1.5% to $3.62. Closed at $3.62, -1.49% vs the prior close of $3.68. Day range $3.53–$3.72, opened at $3.70.
CLGN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CLGN dips 1.5% to $3.62
- Closed at $3.62, -1.49% vs the prior close of $3.68. Day range $3.53–$3.72, opened at $3.70.
- Volume was 13.38K shares, 0.0x its 50-day average of 460.93K — lighter than usual.
- Price is +1.9% vs its 50-day average ($3.56) and -36.0% vs its 200-day average ($5.66).
- 52-week range $2.64–$26.80; today's close sits at 4% of that range, 86.5% below the 52-week high.
Oct 15, 2026 — CLGN slides 10.9% to $3.68
- Closed at $3.68, -10.90% vs the prior close of $4.13. Day range $3.59–$4.01, opened at $4.01.
- Volume was 72.20K shares, 0.2x its 50-day average of 459.59K — lighter than usual.
- Price is +3.6% vs its 50-day average ($3.55) and -35.6% vs its 200-day average ($5.72).
- 52-week range $2.64–$26.80; today's close sits at 4% of that range, 86.3% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — CLGN jumps 5.6% to $4.13
- Closed at $4.13, +5.63% vs the prior close of $3.91. Day range $3.82–$4.13, opened at $4.00.
- Volume was 39.70K shares, 0.1x its 50-day average of 458.84K — lighter than usual.
- Price is +16.7% vs its 50-day average ($3.54) and -28.4% vs its 200-day average ($5.77).
- 52-week range $2.64–$26.80; today's close sits at 6% of that range, 84.6% below the 52-week high.
Oct 13, 2026 — CLGN dips 2.7% to $3.91
- Closed at $3.91, -2.74% vs the prior close of $4.02. Day range $3.85–$4.11, opened at $4.05.
- Volume was 48.00K shares, 0.1x its 50-day average of 457.99K — lighter than usual.
- Price is +11.3% vs its 50-day average ($3.51) and -32.9% vs its 200-day average ($5.83).
- 52-week range $2.64–$26.80; today's close sits at 5% of that range, 85.4% below the 52-week high.
Oct 12, 2026 — CLGN jumps 14.5% to $4.02
- Closed at $4.02, +14.53% vs the prior close of $3.51. Day range $3.50–$4.45, opened at $3.50.
- Volume was 166.60K shares, 0.4x its 50-day average of 454.76K — lighter than usual.
- Price is +14.9% vs its 50-day average ($3.50) and -31.6% vs its 200-day average ($5.88).
- 52-week range $2.64–$26.80; today's close sits at 6% of that range, 85.0% below the 52-week high.
Oct 9, 2026 — CLGN slides 11.6% to $3.51
- Closed at $3.51, -11.59% vs the prior close of $3.97. Day range $3.51–$4.13, opened at $3.88.
- Volume was 182.30K shares, 0.4x its 50-day average of 451.18K — lighter than usual.
- Price is +1.0% vs its 50-day average ($3.47) and -40.8% vs its 200-day average ($5.93).
- 52-week range $2.64–$26.80; today's close sits at 4% of that range, 86.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 8, 2026 — CLGN jumps 14.7% to $3.97
- Closed at $3.97, +14.74% vs the prior close of $3.46. Day range $3.31–$4.16, opened at $3.49.
- Volume was 57.30K shares, 0.1x its 50-day average of 450.06K — lighter than usual.
- Price is +14.6% vs its 50-day average ($3.46) and -33.8% vs its 200-day average ($5.99).
- 52-week range $2.64–$26.80; today's close sits at 6% of that range, 85.2% below the 52-week high.
Oct 7, 2026 — CLGN rises 2.1% to $3.46
- Closed at $3.46, +2.06% vs the prior close of $3.39. Day range $3.31–$3.59, opened at $3.35.
- Volume was 23.10K shares, 0.1x its 50-day average of 449.63K — lighter than usual.
- Price is +0.4% vs its 50-day average ($3.45) and -42.8% vs its 200-day average ($6.05).
- 52-week range $2.64–$26.80; today's close sits at 3% of that range, 87.1% below the 52-week high.
Oct 6, 2026 — CLGN dips 0.6% to $3.39, a 1-month low, 7 down days in a row
- Closed at $3.39, -0.59% vs the prior close of $3.41. Day range $3.25–$3.49, opened at $3.39.
- Volume was 25.00K shares, 0.1x its 50-day average of 449.18K — lighter than usual.
- Price is -1.5% vs its 50-day average ($3.44) and -44.4% vs its 200-day average ($6.10).
- 52-week range $2.64–$26.80; today's close sits at 3% of that range, 87.4% below the 52-week high.
- That makes 7 straight losses.
- SEC filings that day: 6-K.
Oct 5, 2026 — CLGN dips 1.4% to $3.41, 6 down days in a row
- Closed at $3.41, -1.45% vs the prior close of $3.46. Day range $3.40–$3.67, opened at $3.49.
- Volume was 7.20K shares, 0.0x its 50-day average of 449.05K — lighter than usual.
- Price is -0.8% vs its 50-day average ($3.44) and -44.6% vs its 200-day average ($6.15).
- 52-week range $2.64–$26.80; today's close sits at 3% of that range, 87.3% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — CLGN slides 3.1% to $3.46, 5 down days in a row
- Closed at $3.46, -3.08% vs the prior close of $3.57. Day range $3.30–$3.62, opened at $3.62.
- Volume was 45.30K shares, 0.1x its 50-day average of 448.17K — lighter than usual.
- Price is +0.8% vs its 50-day average ($3.43) and -44.3% vs its 200-day average ($6.21).
- 52-week range $2.64–$26.80; today's close sits at 3% of that range, 87.1% below the 52-week high.
- That makes 5 straight losses.
CLGN latest news & SEC filings
Every SEC filing by or about CLGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 8, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 8, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 18, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 3, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade CLGN
- How much it moves: over the last 20 sessions the average daily move was 5.59% (largest 14.7%). That is a volatile stock.
- Liquidity: about 56.97K shares (≈$206.51K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.62 vs a range of $2.64–$26.80 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Sep 4, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 15, 2026; 6-K Oct 9, 2026; 6-K Oct 6, 2026.
- Listing: Nasdaq · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
CLGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.70 | 3.72 | 3.53 | 3.62 | 13.38K |
| Oct 15, 2026 | 4.01 | 4.01 | 3.59 | 3.68 | 72.20K |
| Oct 14, 2026 | 4.00 | 4.13 | 3.82 | 4.13 | 39.70K |
| Oct 13, 2026 | 4.05 | 4.11 | 3.85 | 3.91 | 48.00K |
| Oct 12, 2026 | 3.50 | 4.45 | 3.50 | 4.02 | 166.60K |
| Oct 9, 2026 | 3.88 | 4.13 | 3.51 | 3.51 | 182.30K |
| Oct 8, 2026 | 3.49 | 4.16 | 3.31 | 3.97 | 57.30K |
| Oct 7, 2026 | 3.35 | 3.59 | 3.31 | 3.46 | 23.10K |
| Oct 6, 2026 | 3.39 | 3.49 | 3.25 | 3.39 | 25.00K |
| Oct 5, 2026 | 3.49 | 3.67 | 3.40 | 3.41 | 7.20K |
| Oct 2, 2026 | 3.62 | 3.62 | 3.30 | 3.46 | 45.30K |
| Oct 1, 2026 | 3.84 | 3.84 | 3.55 | 3.57 | 26.20K |
| Sep 30, 2026 | 3.83 | 3.83 | 3.70 | 3.78 | 10.80K |
| Sep 29, 2026 | 3.94 | 3.94 | 3.68 | 3.79 | 21.30K |
| Sep 28, 2026 | 4.26 | 4.30 | 3.75 | 3.87 | 31.20K |
| Sep 25, 2026 | 4.10 | 4.29 | 4.03 | 4.25 | 24.10K |
| Sep 24, 2026 | 4.01 | 4.13 | 3.62 | 4.12 | 121.90K |
| Sep 23, 2026 | 3.76 | 4.13 | 3.71 | 4.04 | 44.20K |
| Sep 22, 2026 | 4.30 | 4.55 | 3.74 | 3.85 | 110.40K |
| Sep 21, 2026 | 4.56 | 4.60 | 4.19 | 4.30 | 69.20K |
About CollPlant Biotechnologies
CollPlant Biotechnologies (CLGN) is listed on the Nasdaq and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in REHOVOT, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1631487.
CLGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hugh M Evans | Director | Apr 27, 2026 |
| Avraham Havron | Director | Mar 18, 2026 |
| Alisa Lask | Director | Mar 18, 2026 |
| Elan Penn | Director | Mar 18, 2026 |
| Yehiel Tal | Chief Executive Officer | Mar 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bar Berta Abelis | VP Legal | Sep 8, 2026 |
| Bowman Bagley | VP Commercial North America | Mar 18, 2026 |
| Philippe Bensimon | VP Regulations and QA | Mar 18, 2026 |
| Oren Fahimipoor | VP Operations | Mar 18, 2026 |
| Eran Rotem | Deputy CEO and CFO | Sep 8, 2026 |
| Jasmine Seror | VP Product Development | Mar 18, 2026 |
| Yehiel Tal | Chief Executive Officer | Mar 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CLGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
CLGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CLGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.